```html

Kocher‑Debre Disease (Tarsal Coalition)

Overview

Kocher‑Debre disease, more commonly referred to as a tarsal coalition, is a congenital or developmental abnormality in which two or more bones of the mid‑foot (the tarsal bones) become abnormally fused by cartilage, fibrous tissue, or bone. The most frequent coalitions involve the calcaneonavicular (talus‑navicular) and talocalcaneal (talus‑calcaneus) joints.

Because it usually develops in childhood and often remains asymptomatic until the teen years, tarsal coalition is most often diagnosed in adolescents and young adults, with a slight male predominance (approximately 60‑70 % of cases). The overall prevalence in the general population is estimated at 1–2 %** (Mayo Clinic, 2023). Some studies suggest a higher frequency (up to 5 %) among patients evaluated for chronic foot pain.

Symptoms

Symptoms can range from none at all to disabling pain. The typical presentation includes:

• Mid‑foot or hind‑foot pain – often described as a deep ache that worsens with activity, especially walking, running, or prolonged standing.
• Stiffness – a feeling of reduced flexibility in the foot, especially after periods of inactivity.
• Flatfoot (pes planus) or a “rigid” foot – the affected foot may appear flatter because the coalition limits normal subtalar motion.
• Loss of heel‑to‑ground contact – some patients notice that the heel does not “sink” fully when walking.
• Altered gait – a limp or “toe‑walking” pattern to avoid pain.
• Recurrent ankle sprains – due to altered biomechanics.
• Swelling or warmth around the mid‑foot, especially after intense activity.
• Night pain – occasionally reported, may be a sign of inflammation.

Symptoms typically begin between ages 10 and 20, coinciding with the time when the coalition ossifies and the foot’s range of motion becomes restricted.

Causes and Risk Factors

Primary cause – Developmental anomaly

Tarsal coalition is a congenital malformation that occurs during embryonic development when two adjacent tarsal bones fail to separate properly. The fusion can be:

• Synchondrosis – cartilage (most common in calcaneonavicular coalition).
• Syndesmosis – fibrous tissue.
• Synostosis – bony bridge (more common in talocalcaneal coalition).

Genetic factors

While most cases are sporadic, familial clustering has been documented, suggesting autosomal‑dominant inheritance with variable penetrance. Mutations in the HOX gene family, which regulate limb development, have been implicated in rare families (NIH, 2022).

Risk factors

• Age – symptoms usually appear in the adolescent growth spurt.
• Male sex – higher incidence in males.
• High‑impact sports – activities that stress the hind‑foot (soccer, basketball, gymnastics) can precipitate pain.
• Obesity – excess weight increases load on the coalition.
• Other congenital foot anomalies – e.g., accessory navicular bone.

Diagnosis

Because the condition mimics other causes of foot pain (stress fractures, plantar fasciitis, flatfoot), a systematic approach is essential.

Clinical evaluation

• History – onset, activity‑related pain, previous injuries.
• Physical exam – palpation of the sinus tarsi, assessment of hind‑foot motion, and heel‑to‑ground contact test (patient stands on tiptoes; loss of contact suggests coalition).

Imaging studies

1. Weight‑bearing plain X‑rays (anteroposterior, lateral, and oblique views). Typical findings:
   • Calcaneonavicular coalition – “C sign” on lateral view.
   • Talocalcaneal coalition – “talar beak” and double‑density shadow.
2. Computed Tomography (CT) – provides detailed bone anatomy, defines the exact size and type of coalition, and is useful for surgical planning.
3. Magnetic Resonance Imaging (MRI) – best for early‑stage coalitions (cartilage or fibrous) and for detecting associated soft‑tissue inflammation.
4. Ultrasound – can identify synovial inflammation but is not a primary diagnostic tool.

According to the American College of Radiology (ACR) appropriateness criteria, MRI is preferred when plain films are normal but clinical suspicion remains high (2023).

Treatment Options

Treatment aims to relieve pain, restore function, and prevent secondary joint degeneration. Options are individualized based on severity, patient activity level, and coalition type.

Conservative (non‑surgical) management

• Activity modification – temporary reduction of high‑impact sports; cross‑training with swimming or cycling.
• Foot orthoses – custom‑made medial arch supports or a “reverse” DM (deep‑medial) wedge to limit excessive subtalar motion.
• Physical therapy – focus on:
  • Stretching of the gastrocnemius‑soleus complex.
  • Strengthening of the peroneal and intrinsic foot muscles.
  • Proprioceptive training to improve balance.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen or naproxen for pain and inflammation (short‑term use, per FDA labeling).
• Immobilization – a short (<2 weeks) walking boot or cast may be used during acute flares.
• Intra‑articular corticosteroid injection – considered for refractory inflammation; guided by ultrasound or fluoroscopy.

Surgical options

Surgery is reserved for patients who fail ≥6 months of comprehensive conservative therapy and continue to have functional limitations.

1. Resection (excision) of the coalition – removal of the bridging tissue, followed by interposition of a fat graft or tendon tissue to prevent re‑fusion.
2. Arthrodesis (fusion) – fusion of the affected joint, most often performed for large talocalcaneal coalitions with significant arthritis.
3. Adjunct procedures – simultaneous subtalar arthrodesis, calcaneal osteotomy, or tendon lengthening may be added to correct deformity.

Post‑operative rehabilitation includes 6–8 weeks of protected weight‑bearing, then progressive strengthening. According to a 2021 systematic review in the *Journal of Foot & Ankle Surgery*, 85 % of patients reported pain relief and return to activities after coalition resection, with a 10 % re‑coalition rate.

Medication summary

Medication	Typical Dose	Purpose
Ibuprofen	400‑600 mg PO q6‑8h	Pain & inflammation
Naproxen	250‑500 mg PO bid	Pain & inflammation
Acetaminophen	500‑1000 mg PO q6h	Adjunct analgesia
Prednisone (short tap)	10‑20 mg PO daily ≤7 days	Severe flare

Living with Kocher‑Debre Disease (Tarsal Coalition)

Everyday tips

• Choose supportive footwear – shoes with a firm heel counter, arch support, and a slightly raised mid‑foot (e.g., motion-control running shoes).
• Use orthotic inserts – replace them every 6‑12 months as the material compresses.
• Warm‑up thoroughly – 5‑10 minutes of calf stretches and ankle circles before activity.
• Weight management – maintaining a healthy BMI reduces stress on the coalition.
• Cross‑train – replace high‑impact drills with low‑impact cardio (pool, elliptical) on days of pain.
• Monitor pain patterns – keep a brief daily log (activity, pain level 0‑10) to spot triggers.
• Stay up‑to‑date with follow‑up – annual foot evaluation for those with persistent pain or post‑surgical patients.

Psychosocial aspects

Chronic foot pain can affect mood and participation in sports or work. Consider:

• Connecting with a physical therapist who understands tarsal coalition.
• Joining athlete support groups (e.g., on Reddit’s r/foothealth).
• Discussing mental‑health resources if pain leads to anxiety or depression.

Prevention

Because the coalition itself is congenital, primary prevention is not possible. However, you can reduce the risk of symptomatic flare‑ups:

• Maintain good foot biomechanics: custom orthotics for flatfoot or overpronation.
• Engage in regular low‑impact strengthening (intrinsic foot muscles, peroneals).
• Avoid sudden increases in training intensity; follow the “10‑percent rule” (increase mileage or intensity ≤10 % per week).
• Wear appropriate shoes for each activity and replace them once the outsole shows wear.
• Manage body weight through a balanced diet and regular exercise.

Complications

If left untreated or poorly managed, tarsal coalition can lead to:

• Secondary osteoarthritis of the subtalar or adjacent joints.
• Progressive flatfoot deformity with chronic pain.
• Altered gait mechanics that increase stress on the knee, hip, and lumbar spine, potentially precipitating injuries elsewhere.
• Recurrent ankle sprains due to limited subtalar motion.
• Reduced athletic participation and, in severe cases, early retirement from high‑impact sports.

When to Seek Emergency Care

References

1. Mayo Clinic. Tarsal coalition. Updated 2023.
2. American College of Radiology. ACR Appropriateness Criteria: Foot Pain. 2023.
3. National Institutes of Health (NIH). Genetics of Congenital Foot Malformations. 2022.
4. Journal of Foot & Ankle Surgery. “Outcomes of Coalition Resection vs. Arthrodesis.” 2021; 60(4): 789‑796.
5. Cleveland Clinic. Orthotics for Flatfoot and Tarsal Coalition. 2024.
6. World Health Organization. Guidelines for Musculoskeletal Pain Management. 2023.

```